Analysts expect 2020 to be a busy year for M&A activity.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
Special controls are also provided for reasonable assurance of the safety and effectiveness of the devices impacted by the reclassification.
Patients are demanding the same type of convenience in healthcare management as they have in the rest of their daily lives.
2020 should be a pivotal year in which the microcosm of medical devices moves out of the shadows and joins the mainstream healthcare conversation.
This two-part virtual workshop will guide participants through the process of how to write effective documents.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
It’s time for medtech design engineers to take a page from the enterprise security playbook.
A look at IP litigation in 2019 and the year ahead, and some advice on how medical device companies can safeguard their intellectual property.